Information
GEXVal to Present at Bio€quity Europe 2025New!!

Read more
Information
Data-Driven Drug Discovery Platform "RePhaIND®" to be Presented at the Pharmaceutical Society of Japan Annual Meeting

GEXVal Inc.March 14, 2025   Data-Driven Drug Discovery Platform "RePhaIND®︎" to be Presented at the Pharmaceut […]

Read more
Information
GEXVal to Participate in BIO-EUROPE SPRING® (MILAN) 2025

Read more
IR
Series C Round Completed, Securing a Total of JPY 910 Million

GEXVal Inc.February 21, 2025 Series C Extension Round Completed: Achieved Total Series C Funding of JPY 910 Mi […]

Read more
Information
Our pipeline information has been updated

GEXVal Inc.February 14, 2025 Our pipeline information has been updated. Pipeline - GEXVal For further informat […]

Read more